Gowling WLG has advised Amphista Theraperutics on the deal.The deal concerns an agreement with Merck Healthcare to collaborate in developing novel protein degrading therapeutics in indications…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
